Yaanu Jeyakumar, Ravi Retnakaran, Denice S Feig, Bernard Zinman, Caroline K Kramer
{"title":"The effect of time-restricted eating accompanied by weight loss on thyroid function in adults with type 2 diabetes.","authors":"Yaanu Jeyakumar, Ravi Retnakaran, Denice S Feig, Bernard Zinman, Caroline K Kramer","doi":"10.1210/jendso/bvag216","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Time-restricted eating (TRE) is a lifestyle intervention associated with beneficial cardiometabolic effects. The impact of TRE-induced weight reduction on thyroid hormonal responses is not well elucidated.</p><p><strong>Objective: </strong>To evaluate the effects of TRE accompanied by weight loss on thyroid function in adults with obesity and type 2 diabetes (T2DM).</p><p><strong>Methods: </strong>We performed an exploratory analysis of a randomized, crossover, open-label study in adults with obesity and T2DM who underwent 2 dietary interventions: TRE and standard lifestyle. Each intervention period lasted 6 weeks. Thyroid function was assessed by TSH, free T4 (fT4), free T3 (fT3), and reverse T3 (rT3).</p><p><strong>Results: </strong>Thirty-nine participants without known thyroid disease (age 56.3 years, 35.9% male, body mass index 32.4 ± 5.7 kg/m<sup>2</sup>) were included. TRE induced significant weight loss (-2.93 kg) compared to the standard lifestyle period (0.59 kg) (mean differences between intervention periods of -3.50 kg ± 2.9; <i>P</i> < .001). Despite this robust weight-lowering effect, there were no significant differences in TSH (0.49 mUI/L ± 3.0; <i>P</i> = .32), fT3 (-0.57 pmol/L ± 2.7; <i>P</i> = .19), fT4 (fT4 -0.55 pmol/L ± 3.8; <i>P</i> = .38), and rT3 (-0.94 ng/dL ± 5.9; <i>P</i> = .350) between intervention periods. Reinforcing these findings, there was no treatment effect interaction on any thyroid function test evaluated. In addition, there was no significant change in the fT3: fT4 and fT3:rT3 ratios between treatment interventions.</p><p><strong>Conclusion: </strong>Despite inducing significant weight loss, TRE did not exert a significant effect on thyroid function in individuals with obesity and early T2DM.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"10 10","pages":"bvag216"},"PeriodicalIF":4.4000,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13624272/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvag216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Context: Time-restricted eating (TRE) is a lifestyle intervention associated with beneficial cardiometabolic effects. The impact of TRE-induced weight reduction on thyroid hormonal responses is not well elucidated.
Objective: To evaluate the effects of TRE accompanied by weight loss on thyroid function in adults with obesity and type 2 diabetes (T2DM).
Methods: We performed an exploratory analysis of a randomized, crossover, open-label study in adults with obesity and T2DM who underwent 2 dietary interventions: TRE and standard lifestyle. Each intervention period lasted 6 weeks. Thyroid function was assessed by TSH, free T4 (fT4), free T3 (fT3), and reverse T3 (rT3).
Results: Thirty-nine participants without known thyroid disease (age 56.3 years, 35.9% male, body mass index 32.4 ± 5.7 kg/m2) were included. TRE induced significant weight loss (-2.93 kg) compared to the standard lifestyle period (0.59 kg) (mean differences between intervention periods of -3.50 kg ± 2.9; P < .001). Despite this robust weight-lowering effect, there were no significant differences in TSH (0.49 mUI/L ± 3.0; P = .32), fT3 (-0.57 pmol/L ± 2.7; P = .19), fT4 (fT4 -0.55 pmol/L ± 3.8; P = .38), and rT3 (-0.94 ng/dL ± 5.9; P = .350) between intervention periods. Reinforcing these findings, there was no treatment effect interaction on any thyroid function test evaluated. In addition, there was no significant change in the fT3: fT4 and fT3:rT3 ratios between treatment interventions.
Conclusion: Despite inducing significant weight loss, TRE did not exert a significant effect on thyroid function in individuals with obesity and early T2DM.